ESMO 2021—highlights in colorectal cancer

This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and CodeBreaK101 trials, (2) positive phase 3 data on the possible ro...

Descripción completa

Detalles Bibliográficos
Autor principal: Weiss, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047589/
https://www.ncbi.nlm.nih.gov/pubmed/35505999
http://dx.doi.org/10.1007/s12254-022-00808-7
_version_ 1784695759872983040
author Weiss, Lukas
author_facet Weiss, Lukas
author_sort Weiss, Lukas
collection PubMed
description This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and CodeBreaK101 trials, (2) positive phase 3 data on the possible role of selective internal radiotherapy (SIRT) in the second-line treatment of liver-limited metastatic CRC, and (3) the impact of the coronavirus disease 2019 (COVID-19) pandemic on CRC screening, management and mortality, now and in the upcoming years.
format Online
Article
Text
id pubmed-9047589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-90475892022-04-29 ESMO 2021—highlights in colorectal cancer Weiss, Lukas Memo Short Review This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and CodeBreaK101 trials, (2) positive phase 3 data on the possible role of selective internal radiotherapy (SIRT) in the second-line treatment of liver-limited metastatic CRC, and (3) the impact of the coronavirus disease 2019 (COVID-19) pandemic on CRC screening, management and mortality, now and in the upcoming years. Springer Vienna 2022-04-28 2022 /pmc/articles/PMC9047589/ /pubmed/35505999 http://dx.doi.org/10.1007/s12254-022-00808-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Review
Weiss, Lukas
ESMO 2021—highlights in colorectal cancer
title ESMO 2021—highlights in colorectal cancer
title_full ESMO 2021—highlights in colorectal cancer
title_fullStr ESMO 2021—highlights in colorectal cancer
title_full_unstemmed ESMO 2021—highlights in colorectal cancer
title_short ESMO 2021—highlights in colorectal cancer
title_sort esmo 2021—highlights in colorectal cancer
topic Short Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047589/
https://www.ncbi.nlm.nih.gov/pubmed/35505999
http://dx.doi.org/10.1007/s12254-022-00808-7
work_keys_str_mv AT weisslukas esmo2021highlightsincolorectalcancer

Ejemplares similares